Insight Accelerator Labs Overview
- Founded
-
1988

- Status
-
Acquired/Merged
- Employees
-
50

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
- Investments
-
22
Insight Accelerator Labs General Information
Description
Provider of healthcare-focused design and innovation consultancy. The company delivers innovation in both medical and drug delivery devices services spanning the full development life cycle from early user research and human factors through to verification and design transfer intended to helped clients discover, innovate, and develop new product solutions through a user-centered design approach.
Contact Information
Website
www.insightpd.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Consulting Services (B2B)
Parent Company
Primary Office
- 4660 North Ravenswood Avenue
- Chicago, IL 60640
- United States
+1 (773) 000-0000
Insight Accelerator Labs Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Insight Accelerator Labs Executive Team (4)
Insight Accelerator Labs Signals
Insight Accelerator Labs Investments (22)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000000 | 21-Mar-2023 | 0000000000 | Decision/Risk Analysis | ||
00000 0000000 | 01-Jan-2022 | 0000000000 | Surgical Devices | ||
000000 000000 | 01-Jan-2021 | 0000000000 | 0000 | Other Healthcare Technology Systems | |
0000000000 | 01-Jan-2021 | 0000000000 | 0000 | Diagnostic Equipment | |
Wave Therapeutics | 20-Nov-2020 | Grant | Therapeutic Devices |
Insight Accelerator Labs Exits (6)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
00000 000000 | 01-Jan-2019 | 000000000000000000 | Completed |
|
|
000000 0000000 | 27-Feb-2015 | 000000000000000000 | Completed |
|
|
0000000-000 | 26-Jun-2014 | 000000000000000000 | Completed |
|
|
000000 0000 | 03-Feb-2014 | 0000 00000 | 00000 | Completed |
|
Oriel Therapeutics | 24-Sep-2008 | Later Stage VC | 000.00 | Completed |
|